- Human pathology

Home > A. Molecular pathology > Targeted therapy > HSP90 inhibitors

HSP90 inhibitors

Monday 2 May 2016

hsp90 inhibitors


An Hsp90 inhibitor is a substance that inhibits that activity of the Hsp90 heat shock protein. Since Hsp90 stabilizes a variety of proteins required for survival of cancer cells, these substances may have therapeutic benefit in the treatment of various types of malignancies.

Furthermore a number of Hsp90 inhibitors are currently undergoing clinical trials for a variety of cancers.

Hsp90 inhibitors include the natural products geldanamycin and radicicol as well as semisynthetic derivatives 17-N-Allylamino-17-demethoxygeldanamycin (17AAG).


- gaminitrib
- NVP-AUY922

See also

- HSP90
- targeted therapy